[{"address1": "2001 Market Street", "address2": "Suite 3915 Unit #15", "city": "Philadelphia", "state": "PA", "zip": "19103", "country": "United States", "phone": "267-225-7416", "website": "https://www.contexttherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Martin A. Lehr", "age": 40, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 765596, "exercisedValue": 0, "unexercisedValue": 27676}, {"maxAge": 1, "name": "Ms. Jennifer  Minai-Azary", "age": 46, "title": "CFO & Treasurer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 564090, "exercisedValue": 0, "unexercisedValue": 15208}, {"maxAge": 1, "name": "Mr. Alex C. Levit Esq., J.D.", "age": 45, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 541334, "exercisedValue": 0, "unexercisedValue": 14582}, {"maxAge": 1, "name": "Mr. Christopher  Beck M.B.A.", "title": "Senior Vice President of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Dashnau M.B.A., Ph.D.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karen  Chagin M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.5637, "open": 0.59, "dayLow": 0.5717, "dayHigh": 0.6189, "regularMarketPreviousClose": 0.5637, "regularMarketOpen": 0.59, "regularMarketDayLow": 0.5717, "regularMarketDayHigh": 0.6189, "payoutRatio": 0.0, "beta": 1.859, "forwardPE": -1.9744829, "volume": 151029, "regularMarketVolume": 151029, "averageVolume": 245582, "averageVolume10days": 458990, "averageDailyVolume10Day": 458990, "bid": 0.4095, "ask": 0.7433, "bidSize": 2, "askSize": 2, "marketCap": 51364624, "fiftyTwoWeekLow": 0.49, "fiftyTwoWeekHigh": 2.75, "fiftyDayAverage": 0.73988, "twoHundredDayAverage": 1.230925, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -37793900, "profitMargins": 0.0, "floatShares": 39385523, "sharesOutstanding": 89704200, "sharesShort": 2232539, "sharesShortPriorMonth": 2198107, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.0249, "heldPercentInsiders": 0.02325, "heldPercentInstitutions": 0.79933, "shortRatio": 14.28, "shortPercentOfFloat": 0.030199999, "impliedSharesOutstanding": 89704200, "bookValue": 1.014, "priceToBook": 0.5646942, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -27634568, "trailingEps": -0.28, "forwardEps": -0.29, "enterpriseToEbitda": 1.195, "52WeekChange": -0.737156, "SandP52WeekChange": 0.09544468, "quoteType": "EQUITY", "currentPrice": 0.5726, "targetHighPrice": 9.0, "targetLowPrice": 4.0, "targetMeanPrice": 5.75, "targetMedianPrice": 5.0, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 89352224, "totalCashPerShare": 0.996, "ebitda": -31617174, "totalDebt": 193706, "quickRatio": 47.024, "currentRatio": 48.802, "debtToEquity": 0.213, "returnOnAssets": -0.38009998, "returnOnEquity": -0.55588, "freeCashflow": -36900256, "operatingCashflow": -15224195, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CNTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Context Therapeutics Inc.", "regularMarketChangePercent": 1.57885, "regularMarketPrice": 0.5726, "corporateActions": [], "postMarketTime": 1750461000, "regularMarketTime": 1750449602, "exchange": "NCM", "messageBoardId": "finmb_408000800", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "Context Therapeutics Inc.", "ipoExpectedDate": "2021-10-20", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1634736600000, "postMarketChangePercent": 4.78519, "postMarketPrice": 0.6, "postMarketChange": 0.0274, "regularMarketChange": 0.00889999, "regularMarketDayRange": "0.5717 - 0.6189", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 245582, "fiftyTwoWeekLowChange": 0.0826, "fiftyTwoWeekLowChangePercent": 0.16857143, "fiftyTwoWeekRange": "0.49 - 2.75", "fiftyTwoWeekHighChange": -2.1774, "fiftyTwoWeekHighChangePercent": -0.79178184, "fiftyTwoWeekChangePercent": -73.7156, "earningsTimestamp": 1746648597, "earningsTimestampStart": 1746648597, "earningsTimestampEnd": 1746648597, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.28, "epsForward": -0.29, "epsCurrentYear": -0.245, "priceEpsCurrentYear": -2.337143, "fiftyDayAverageChange": -0.16728002, "fiftyDayAverageChangePercent": -0.22609073, "twoHundredDayAverageChange": -0.65832496, "twoHundredDayAverageChangePercent": -0.53482133, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "trailingPegRatio": null, "__fetch_time": "2025-06-21"}]